Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v1-EN
Language French English
Date Updated 2019-04-11 2018-09-21
Drug Identification Number 02247916 02247916
Brand name CIPRO XL CIPRO XL
Common or Proper name Ciprofloxacin Extended Release Tablet Ciprofloxacin Extended Release Tablet
Company Name BAYER INC BAYER INC
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 500MG 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 50's 50's
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-10-15 2018-10-15
Actual start date
Estimated end date 2019-07-18 2019-02-08
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments